Ophthalmic presentation and outcomes of rhino-orbito-cerebral mucormycosis during the COVID-19 pandemic: An 18-month follow-up report
-
Published:2024-05
Issue:5
Volume:47
Page:104139
-
ISSN:0181-5512
-
Container-title:Journal Français d'Ophtalmologie
-
language:en
-
Short-container-title:Journal Français d'Ophtalmologie
Author:
Veisi A.ORCID,
Aletaha M.,
Abolhosseini M.,
Ownagh V.,
Fekri S.,
Feizi M.,
Amoushahi Khouzani S.,
Najafi M.
Reference38 articles.
1. Characterization of bacterial and fungal infections in hospitalized patients with coronavirus disease 2019 and factors associated with health care-associated infection;Kubin;Open Forum Infect Dis,2021
2. Epidemiology and diagnosis of mucormycosis: an update;Skiada;J Fungi,2020
3. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China;Wang;JAMA,2020
4. A prospective multicenter study on Mucormycosis in India: epidemiology, diagnosis, and treatment;Prakash;Med Mycol,2019
5. COVID-19–associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis;Bhattacharyya;Indian J Pharmacol,2021